Sarcopenia and sarcopenic obesity in patients with muscular dystrophy

Frontiers in Aging Neuroscience

Volumn 6, Issue OCT, 2014, Pages

  Merlini, Luciano ^a   Vagheggini, Alessandro ^b   Cocchi, Daniela ^b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Body composition; Muscle strength; Muscular dystrophy; Physical performance; Sarcopenia; Sarcopenic obesity

Indexed keywords

ADULT; AGING; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYNAMOMETRY; FEMALE; HUMAN; MALE; MUSCLE MASS; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; OBESITY; PHYSICAL PERFORMANCE; RESPIRATORY FUNCTION; SARCOPENIA; SKELETAL MUSCLE;

EID: 84926637656     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00274     Document Type: Article

References (52)

1. Batsis, J.A., Barre, L.K., Mackenzie, T.A., Pratt, S.I., Lopez-Jimenez, F., and Bartels, S.J. (2013). Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the national health and nutrition examination survey 1999-2004. J. Am. Geriatr. Soc. 61, 974-980. doi: 10.1111/jgs.12260
2. Baumgartner, R.N., Koehler, K.M., Gallagher, D., Romero, L., Heymsfield, S.B., Ross, R.R., et al. (1998). Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147, 755-763. doi:10.1093/oxfordjournals.aje.a009520
3. Baumgartner, R.N., Wayne, S.J., Waters, D.L., Janssen, I., Gallagher, D., and Morley, J.E. (2004). Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12, 1995-2004. doi:10.1038/oby.2004.250
4. Beenakker, E.A., van der Hoeven, J.H., Fock, J.M., and Maurits, N.M. (2001). Reference values of maximum isometric muscle force obtained in 270 children aged 4-16 years by hand-held dynamometry. Neuromuscul. Disord. 11, 441-446. doi:10.1016/S0960-8966(01)00193-6
5. Bohannon, R.W., Peolsson, A., Massy-Westropp, N., Desrosiers, J., and Bear-Lehman, J. (2006). Reference values for adult grip strength measured with a Jamar dynamometer: a descriptive meta-analysis. Physiotherapy 92, 11-15. doi:10.1016/j.physio.2005.05.003
6. Calvani, R., Joseph, A.M., Adhihetty, P.J., Miccheli, A., Bossola, M., Leeuwenburgh, C., et al. (2013). Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol. Chem. 394, 393-414. doi:10.1515/hsz-2012-0247
7. Canton, M., Menazza, S., and Di Lisa, F. (2014). Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets. J. Muscle Res. Cell. Motil. 35, 23-36. doi:10.1007/s10974-014-9380-2
8. Coin, A., Sergi, G., Minicuci, N., Giannini, S., Barbiero, E., Manzato, E., et al. (2008). Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population. Clin. Nutr. 27, 87-94. doi:10.1016/j.clnu.2007.10.008
9. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al. (2010). Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 39, 412-423. doi:10.1093/ageing/afq034
10. Deldicque, L. (2013). Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia? Front. Physiol. 4, 236. doi:10.3389/fphys.2013.00236
11. Doria, E., Buonocore, D., Focarelli, A., and Marzatico, F. (2012). Relationship between human aging muscle and oxidative system pathway. Oxid. Med. Cell. Longev. 2012, 830257. doi:10.1155/2012/830257
12. Emery, A.E. (2002). The muscular dystrophies. Lancet 359, 687-695. doi:10.1016/S0140-6736(02)07815-7
13. Faulkner, J.A., Larkin, L.M., Claflin, D.R., and Brooks, S.V. (2007). Age-related changes in the structure and function of skeletal muscles. Clin. Exp. Pharmacol. Physiol. 34, 1091-1096. doi:10.1111/j.1440-1681.2007.04752.x
14. Fielding, R.A., Vellas, B., Evans, W.J., Bhasin, S., Morley, J.E., Newman, A.B., et al. (2011). Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249-256. doi:10.1016/j.jamda.2011.01.003
15. Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., et al. (2001). Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56, M146-M156. doi:10.1093/gerona/56.3.M146
16. Gualandi, F., Curci, R., Sabatelli, P., Martoni, E., Bovolenta, M., Maraldi, N.M., et al. (2011). Macrophages: a minimally invasive tool for monitoring collagen VI myopathies. Muscle Nerve 44, 80-84. doi:10.1002/mus.21999
17. Gualandi, F., Urciuolo, A., Martoni, E., Sabatelli, P., Squarzoni, S., Bovolenta, M., et al. (2009). Autosomal recessive Bethlem myopathy. Neurology 73, 1883-1891. doi:10.1212/WNL.0b013e3181c3fd2a
18. Hasegawa, R., Islam, M.M., Lee, S.C., Koizumi, D., Rogers, M.E., and Takeshima, N. (2008). Threshold of lower body muscular strength necessary to perform ADL independently in community-dwelling older adults. Clin. Rehabil. 22, 902-910. doi:10.1177/0269215508094713
19. Irwin, W.A., Bergamin, N., Sabatelli, P., Reggiani, C., Megighian, A., Merlini, L., et al. (2003). Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat. Genet. 35, 367-371. doi:10.1038/ng1270
20. Jankowski, C.M., Gozansky, W.S., Van Pelt, R.E., Schenkman, M.L., Wolfe, P., Schwartz, R.S., et al. (2008). Relative contributions of adiposity and muscularity to physical function in community-dwelling older adults. Obesity (Silver Spring) 16, 1039-1044. doi:10.1038/oby.2007.84
21. Jiang, C., Wen, Y., Kuroda, K., Hannon, K., Rudnicki, M.A., and Kuang, S. (2014). Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy. Dis. Model Mech. 7, 997-1004. doi:10.1242/dmm.015917
22. Kissel, J.T., McDermott, M.P., Mendell, J.R., King, W.M., Pandya, S., Griggs, R.C., et al. (2001). Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57, 1434-1440. doi:10.1212/WNL.57.8.1434
23. Langlois, J.A., Keyl, P.M., Guralnik, J.M., Foley, D.J., Marottoli, R.A., and Wallace, R.B. (1997). Characteristics of older pedestrians who have difficulty crossing the street. Am. J. Public Health 87, 393-397. doi:10.2105/AJPH.87.3.393
24. Lauretani, F., Russo, C.R., Bandinelli, S., Bartali, B., Cavazzini, C., Di Iorio, A., et al. (2003). Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J. Appl. Physiol. 95, 1851-1860. doi:10.1152/japplphysiol.00246.2003
25. Lucioli, S., Giusti, B., Mercuri, E., Vanegas, O.C., Lucarini, L., Pietroni, V., et al. (2005). Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Neurology 64, 1931-1937. doi:10.1212/01.WNL.0000163990.00057.66
26. Martoni, E., Urciuolo, A., Sabatelli, P., Fabris, M., Bovolenta, M., Neri, M., et al. (2009). Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy. Hum. Mutat. 30, E662-E672. doi:10.1002/humu.21022
27. Marzetti, E., Calvani, R., Cesari, M., Buford, T.W., Lorenzi, M., Behnke, B.J., et al. (2013). Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int. J. Biochem. Cell Biol. 45, 2288-2301. doi:10.1016/j.biocel.2013.06.024
28. Marzetti, E., and Leeuwenburgh, C. (2006). Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp. Gerontol. 41, 1234-1238. doi:10.1016/j.exger.2006.08.011
29. Merlini, L., Angelin, A., Tiepolo, T., Braghetta, P., Sabatelli, P., Zamparelli, A., et al. (2008a). Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc. Natl. Acad. Sci. U.S.A. 105, 5225-5229. doi:10.1073/pnas.0800962105
30. Merlini, L., Martoni, E., Grumati, P., Sabatelli, P., Squarzoni, S., Urciuolo, A., et al. (2008b). Autosomal recessive myosclerosis myopathy is a collagen VI disorder. Neurology 71, 1245-1253. doi:10.1212/01.wnl.0000327611.01687.5e
31. Merlini, L., Bertini, E., Minetti, C., Mongini, T., Morandi, L., Angelini, C., et al. (2004). Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve 29, 548-552. doi:10.1002/mus.20018
32. Merlini, L., Mazzone, E.S., Solari, A., and Morandi, L. (2002). Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve 26, 64-70. doi:10.1002/mus.10166
33. Merlini, L., Nishino, I., Consortium for Autophagy in Muscular Dystrophies. (2014). 201st ENMC international workshop: autophagy in muscular dystrophies - translational approach, 1-3 November 2013, Bussum, The Netherlands. Neuromuscul. Disord. 24, 546-561. doi:10.1016/j.nmd.2014.03.009
34. Merlini, L., Solari, A., Vita, G., Bertini, E., Minetti, C., Mongini, T., et al. (2003). Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study. J. Child Neurol. 18, 537-541. doi:10.1177/08830738030180080501
35. Mijnarends, D.M., Meijers, J.M., Halfens, R.J., Ter Borg, S., Luiking, Y.C., Verlaan, S., et al. (2013). Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J. Am. Med. Dir. Assoc. 14, 170-178. doi:10.1016/j.jamda.2012.10.009
36. Muscaritoli, M., Anker, S.D., Argiles, J., Aversa, Z., Bauer, J.M., Biolo, G., et al. (2010). Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin. Nutr. 29, 154-159. doi:10.1016/j.clnu.2009.12.004
37. Newman, A.B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., et al. (2003). Sarcopenia: alternative definitions and associations with lower extremity function. J. Am. Geriatr. Soc. 51, 1602-1609. doi:10.1046/j.1532-5415.2003.51534.x
38. Pepe, G., Giusti, B., Bertini, E., Brunelli, T., Saitta, B., Comeglio, P., et al. (1999). A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an Italian family affected by Bethlem myopathy. Biochem. Biophys. Res. Commun. 258, 802-807. doi:10.1006/bbrc.1999.0680
39. Ploutz-Snyder, L.L., Manini, T., Ploutz-Snyder, R.J., and Wolf, D.A. (2002). Functionally relevant thresholds of quadriceps femoris strength. J. Gerontol. A Biol. Sci. Med. Sci. 57, B144-B152. doi:10.1093/gerona/57.4.B144
40. Pruna, L., Chatelin, J., Pascal-Vigneron, V., and Kaminsky, P. (2011). Regional body composition and functional impairment in patients with myotonic dystrophy. Muscle Nerve 44, 503-508. doi:10.1002/mus.22099
41. Sabatelli, P., Gara, S.K., Grumati, P., Urciuolo, A., Gualandi, F., Curci, R., et al. (2011). Expression of the collagen VI alpha5 and alpha6 chains in normal human skin and in skin of patients with collagen VI-related myopathies. J. Invest. Dermatol. 131, 99-107. doi:10.1038/jid.2010.284
42. Sabatelli, P., Palma, E., Angelin, A., Squarzoni, S., Urciuolo, A., Pellegrini, C., et al. (2012). Critical evaluation of the use of cell cultures for inclusion in clinical trials of patients affected by collagen VI myopathies. J. Cell. Physiol. 227, 2927-2935. doi:10.1002/jcp.23039
43. Skalsky, A.J., Abresch, R.T., Han, J.J., Shin, C.S., and McDonald, C.M. (2008). The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul. Disord. 18, 873-880. doi:10.1016/j.nmd.2008.07.005
44. Skalsky, A.J., Han, J.J., Abresch, R.T., Shin, C.S., and McDonald, C.M. (2009). Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Muscle Nerve 39, 647-651. doi:10.1002/mus.21212
45. Stenholm, S., Harris, T.B., Rantanen, T., Visser, M., Kritchevsky, S.B., and Ferrucci, L. (2008). Sarcopenic obesity: definition, cause and consequences. Curr. Opin. Clin. Nutr. Metab. Care 11, 693-700. doi:10.1097/MCO.0b013e328312c37d
46. Tanko, L.B., Movsesyan, L., Mouritzen, U., Christiansen, C., and Svendsen, O.L. (2002). Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metab. Clin. Exp. 51, 69-74. doi:10.1053/meta.2002.28960
47. Thornell, L.E. (2011). Sarcopenic obesity: satellite cells in the aging muscle. Curr. Opin. Clin. Nutr. Metab. Care 14, 22-27. doi:10.1097/MCO.0b013e3283412260
48. van der Kooi, A.J., De Voogt, W.G., Bertini, E., Merlini, L., Talim, F.B., Ben Yaou, R., et al. (2006). Cardiac and pulmonary investigations in Bethlem myopathy. Arch. Neurol. 63, 1617-1621. doi:10.1001/archneur.63.11.1617
49. van der Ploeg, R.J., Fidler, V., and Oosterhuis, H.J. (1991). Hand-held myometry: reference values. J. Neurol. Neurosurg. Psychiatr. 54, 244-247. doi:10.1136/jnnp.54.3.244
50. Vuillerot, C., Braillon, P., Fontaine-Carbonnel, S., Rippert, P., Andre, E., Iwaz, J., et al. (2014). Influence of a two-year steroid treatment on body composition as measured by dual X-ray absorptiometry in boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 24, 467-473. doi:10.1016/j.nmd.2014.03.002
51. WHO. (2000). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 894, i-xii, 1-253.
52. Wohlgemuth, S.E., Seo, A.Y., Marzetti, E., Lees, H.A., and Leeuwenburgh, C. (2010). Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp. Gerontol. 45, 138-148. doi:10.1016/j.exger.2009.11.002